AlphaFold-Multimer predicts 2,895 interactions among human mitochondrial proteins
Texas A&M AgriLife Research screened 630,003 protein pairs from about 1,100 human mitochondrial proteins with AlphaFold-Multimer and identified 2,895 likely interactions, more than half not previously reported, giving 85 uncharacterized proteins their first probable partners. The paper appeared in Nature Communications on 25 August 2026 and the institutional release on 5 November. Lab experiments in yeast and human cells confirmed several of the partnerships; most predictions remain untested, and the disease links are potential targets, not established ones. Predictions are shared through the MitoMatch web tool.
Technology: AlphaFold-Multimer
Family AlphaFold: profile · models page
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: AlphaFold-Multimer screened about 630,000 protein pairs; lab experiments in yeast and human cells confirmed several of the predicted partnerships, while the release does not say how many of the 2,895 were tested.
- Still unknown: Only several predictions were confirmed, most remain unverified, the interactions are described as likely rather than established, and disease links are potential targets.
- AI role: AlphaFold-Multimer predicted pairwise interactions among mitochondrial proteins; the predictions were released as the MitoMatch web resource.
Evidence sources: https://www.eurekalert.org/news-releases/1150930
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: press release. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.